BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24413852)

  • 1. The relationship between epicardial adipose tissue and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zencirci E; Zencirci AE; Değirmencioğlu A; Karakuş G; Uğurlucan M; Özden K; Erdem A; Güllü AÜ; Ekmekçi A; Velibey Y; Erer HB; Çelik S; Akyol A
    Heart Vessels; 2015 Mar; 30(2):147-53. PubMed ID: 24413852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of the No-Reflow Phenomenon and Epicardial Adipose Tissue for Clinical Outcomes After Primary Percutaneous Coronary Intervention.
    Zencirci AE; Zencirci E; Değirmencioğlu A; Erdem A; Karakuş G; Özden K; Karadeniz F; Buturak A; Belen E; Tipi F; Eren M
    Hellenic J Cardiol; 2015; 56(4):311-9. PubMed ID: 26233771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
    Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between Gensini score and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zencirci AE; Zencirci E; Degirmencioglu A; Karakus G; Ugurlucan M; Gunduz S; Ozden K; Erdem A; Karadeniz F; Ekmekci A; Erer H; Sayar N; Eren M
    Kardiol Pol; 2014; 72(6):494-503. PubMed ID: 24408069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of magnetic resonance imaging findings in non-ST-segment elevation versus ST-segment elevation myocardial infarction patients undergoing early invasive intervention.
    Xu J; Song YB; Hahn JY; Chang SA; Lee SC; Choe YH; Choi SH; Choi JH; Lee SH; Oh JK; Gwon HC
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1487-97. PubMed ID: 22072243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial adipose tissue may predict new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction.
    Eren H; Omar MB; Kaya Ü; Öcal L; Yilmaz MF; Akkan S
    J Cardiovasc Med (Hagerstown); 2021 Dec; 22(11):917-923. PubMed ID: 34534154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue.
    Mohamed A
    Clin Cardiol; 2021 Oct; 44(10):1371-1376. PubMed ID: 34255859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Epicardial Adipose Tissue Thickness is Associated With Angiographic Thrombus Burden in the Patients With Non-ST-Segment Elevation Myocardial Infarction.
    Bakirci EM; Degirmenci H; Duman H; Inci S; Hamur H; Buyuklu M; Ceyhun G; Topal E
    Clin Appl Thromb Hemost; 2015 Oct; 21(7):612-8. PubMed ID: 25381157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction.
    Celik T; Kaya MG; Akpek M; Gunebakmaz O; Balta S; Sarli B; Duran M; Demirkol S; Uysal OK; Oguzhan A; Gibson CM
    Angiology; 2015 Feb; 66(2):155-62. PubMed ID: 24301422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.
    Ipek G; Onuk T; Karatas MB; Gungor B; Osken A; Keskin M; Oz A; Tanik O; Hayiroglu MI; Yaka HY; Ozturk R; Bolca O
    Angiology; 2016 Oct; 67(9):840-5. PubMed ID: 26685178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Lei L; Ye H; Peng J
    Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of syntax score and syntax score II to predict "no reflow phenomenon" in patients with ST-segment elevation myocardial infarction.
    Yesin M; Çağdaş M; Kalçık M; Uluganyan M; Efe SÇ; Rencüzoğulları İ; Karabağ Y; Gürsoy MO; Karakoyun S
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1883-1889. PubMed ID: 28664479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.
    Şen Ö; Şen SB; Topuz AN; Topuz M
    Biomark Med; 2021 Oct; 15(15):1357-1366. PubMed ID: 34533051
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
    Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Ikenaga H; Ishihara M; Inoue I; Kawagoe T; Shimatani Y; Miura F; Nakama Y; Dai K; Ohtani T; Ohi K; Miki T; Nakamura M; Kishimoto S; Sumimoto Y; Kihara Y
    J Cardiol; 2013 Aug; 62(2):71-6. PubMed ID: 23680004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.